Biphasic reactions in children undergoing oral food challenges

Juhee Lee1, Jackie P-D Garrett, Terri Brown-Whitehorn

  • 1Division of Allergy and Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Biphasic reactions after pediatric food challenges are rare (1.5%). While clinical features showed no significant differences, severe initial reactions and specific treatments may indicate a higher risk for biphasic reactions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Immunology
  • Food Allergy Research

Background:

  • Biphasic reactions, a recurrence of allergic symptoms after initial improvement, are not well-documented in children.
  • Understanding biphasic reactions is crucial for managing food allergy and oral food challenges (OFCs).

Purpose of the Study:

  • To determine the prevalence of biphasic reactions in children undergoing OFCs.
  • To identify clinical and treatment factors associated with biphasic reactions in pediatric food allergy.

Main Methods:

  • Retrospective chart review of oral food challenges (OFCs) conducted between July 2007 and March 2011.
  • Analysis of charts for 48 hours post-challenge to identify biphasic reactions.
  • Comparison of clinical features and treatments between uniphasic and biphasic reaction groups.

Main Results:

  • A biphasic reaction rate of 1.5% (9 out of 614 positive challenges) was observed.
  • Biphasic reactions occurred in challenges involving eggs, peanuts, and milk, with symptom-free intervals of 2-24 hours.
  • While not statistically significant, biphasic reactions were associated with initial anaphylaxis, multiple organ involvement, and treatments like steroids, epinephrine, and antihistamines.

Conclusions:

  • Biphasic reactions are uncommon in children undergoing OFCs but may be linked to more severe initial allergic responses.
  • A 24-hour observation period may be beneficial for children experiencing severe allergic reactions during OFCs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...